Limb girdle muscular dystrophy: Use of dHPLC and direct sequencing to detect sarcoglycan gene mutations in a New Zealand cohort [2]

Clinical Genetics

Volumn 65, Issue 1, 2004, Pages 55-60

  Hedge, M R ^b   Wu, F ^b   Chong, B ^b   Chin, E L H ^b   Hutchinson, D O ^b   Richards, C S ^b   Khadilkar, S ^b   Love, D R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SARCOGLYCAN;

ADULT; CLINICAL ARTICLE; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LETTER; MALE; MUSCULAR DYSTROPHY; MUTATIONAL ANALYSIS; NEW ZEALAND; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCHOOL CHILD;

ADULT; AGED; BASE SEQUENCE; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COHORT STUDIES; CYTOSKELETAL PROTEINS; DATABASES, GENETIC; DYSTROGLYCANS; EXTREMITIES; FEMALE; GENETIC SCREENING; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUSCULAR DYSTROPHIES; NEW ZEALAND; PEDIGREE; SARCOGLYCANS; SEQUENCE ANALYSIS, DNA;

EID: 1642474045     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j..2004.00193.x     Document Type: Letter

References (28)

1. Walton JN, Nattrass FJ. On the classification, natural history and treatment of the myopathies. Brain 1954: 77: 169-231.
2. Jackson CE, Carey JH. Progressive muscular dystrophy: autosomal recessive type. Pediatrics 1961: 28: 77-84.
3. Roberds SL, Leturcq F, Allamand V et al. Missense mutations in the adhalin gene linked to childhood autosomal recessive muscular dystrophy. Cell 1994: 78: 625-633.
4. Bönnemann CG, Modi R, Noguchi S et al. Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet 1995: 11: 266-273.
5. Lim LE, Duclos F, Broux O et al. Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat Genet 1995: 11: 257-265.
6. Bushby KMD, Beckman JS. Report on the 30th and 31st ENMC International Workshops. Neuromuscul Disord 1995: 5: 337-343.
7. Eymard B, Romero NB, Leturcq F et al. Primary adhalinopathy (alpha-sarcoglycanopathy): clinical, pathologic, and genetic correlation in 20 patients with autosomal recessive muscular dystrophy. Neurology 1997: 48 (5): 1227-1234.
8. Passos-Bueno MR, Vainzof M, Moreira ES, Zatz M. Seven autosomal recessive limb-girdle muscular dystrophies in the Brazilian population: from LGMD2A to LGMD2G. Am J Med Genet 1999: 82: 392-398.
9. Bushby KM. The limb-girdle muscular dystrophies: multiple genes, multiple mechanisms. Hum Mol Genet 1999: 8: 1875-1882.
10. Pogue R, Anderson LVB, Pyle A et al. Strategy for mutation analysis in the autosomal recessive limb-girdle muscular dystrophies. Neuromuscul Disord 2001: 11: 80-87.
11. Ozawa E, Yoshida M, Suzuki A, Mizuno Y, Hagiwara Y, Noguchi S. Dystrohpin-associated proteins in muscular dystrophy. Hum Mol Genet 1996: 4: 1711-1716.
12. Yoshida M, Ozawa E. Glycoprotein complex anchoring dystrophin to sarcolemma. J Biochem 1990: 108: 748-752.
13. Ervasti JM, Campbell KP. Membrane organization of the dystrophin-glycoprotein complex. Cell 1991: 66 (6): 1121-1131.
14. Ervasti JM, Campbell KP. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 1993: 122 (4): 809-823.
15. Crosbie RH, Lim LE, Moore SA, Hirano M, Hays AP, Maybaum SW et al. Molecular and genetic characterization of sarcospan: insights into sarcoglycan-sarcospan interactions. Hum Mol Genet 2000: 9 (13): 2019-2027.
16. Anderson LVB. Optimized protein diagnosis in the autosomal recessive limb-girdle muscular dystrophies. Neuromuscul Disord 1996: 6: 443-446.
17. Sewry CA, Taylor J, Anderson LV et al. Abnormalities in alpha-, beta- and gamma-sarcoglycan in patients with limb-girdle muscular dystrophy. Neuromuscul Disord 1996: 6: 467-474.
18. Bornemann A, Anderson LV. Diagnostic protein expression in human muscle biopsies. Brain Pathol 2000: 10 (2): 193-214.
19. Schollen E, Martens K, Geuzens E, Matthijs G. DHPLC analysis as a platform for molecular diagnosis of congenital disorders of glycosylation (CDG). Eur J Hum Genet 2002: 10 (10): 643-648.
20. Bodamer OA, Bercovich D, Schlabach et al. Use of debaturing HPLC to provide efficient detection of mutations causing familial hypercholesterolemia. Clin Chem 2002: 48 (11): 1913-1918.
21. Hegde MR, Chong B, Stevenson C, Laing N, Khadilkar S, Love DR. Clinical and genetic analysis of four patients with distal upper limb spinal muscular atrophy. Indian J Med Res 2001: 114: 141-147.
22. Moreira ES, Vainzof M, Suzuki OT, Pavanello RC, Zatz M, Passos-Bueno MR. Genotype-phenotype correlations in 35 Brazilian families with sarcoglycanopathies including the description of three novel mutations. J Med Genet 2003: 40 (2): E12.
23. Duggan DJ, Gorospe J, Rafael FM et al. Mutations in the sarcoglycan genes in patients with myopathy. N Engl J Med 1997: 336: 618-624.
24. Piccolo F, Roberds SL, Jeanpierre M et al. Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity. Nat Genet 1995: 10 (2): 243-245.
25. McNally EM, Passos-Bueno MR, Bonnemann CG et al. Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation. Am J Hum Genet 1996: 59 (5): 1040-1047.
26. Nigro V, Piluso G, Belsito A et al. Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein. Hum Mol Genet 1996: 5 (8): 1179-1186.
27. Angelini C, Fanin M, Freda MP, Duggan DJ, Siciliano G, Hoffman EP. The clinical spectrum of sarcoglycanopathies. Neurology 1999: 52: 176.
28. Hayashi YK, Mizuno Y, Yoshida M, Nonaka I, Ozawa E, Arahata K. The frequency of patients with 50-kd dystrophin-associated glycoprotein (50DAG or adhalin) deficiency in a muscular dystrophy patient population in Japan. Neurology 1995: 45: 551-554.